CMS finalizes new drug pricing model: 7 notes
CMS has finalized the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory payment model that will tie Medicare Part B drug rebates to prices paid in 19 reference countries, according to a Sept. 30 CMS news release. Here are seven things to know: The post CMS finalizes new drug pricing model: 7 notes appeared first on Becker's Payer Issues | Payer News .
Also reported by AHA News
View related coverage on the timeline →
Useful signal?
Sign in with GitHub below to react 👍 / 👎, or comment if a category looks wrong — your reactions help curate this feed. How feedback works
Draft Insight Angle
Auto-generated draft — review and edit before any external use.
Policy / Regulatory Changes signal via Becker's Payer Issues: "CMS finalizes new drug pricing model: 7 notes".
Analytic angles
- Compare against the current CMS rate/bid-cycle documents.
- Single-source so far — corroborate against a second outlet.
Draft paragraph
[DRAFT — verify before any external use] Becker's Payer Issues reports on policy / regulatory changes: CMS has finalized the Global Benchmark for Efficient Drug Pricing (GLOBE) Model, a mandatory payment model that will tie Medicare Part B drug rebates to prices paid in 19 reference countries, according to a Sept. 30 CMS…
Note: This is an early signal based on public reporting. Confirm against primary sources before drawing conclusions. Market dynamics may shift as additional information emerges.